key: cord-0770969-uozhkvtu
authors: Li, Guanqiao; Zhou, Yangzhong; Ji, Junyi; Liu, Xiaozhen; Jin, Qiao; Zhang, Linqi
title: Surging publications on the COVID-19 pandemic
date: 2020-09-22
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.09.010
sha: 02f66d1fce665c1c4fdfd6846043d59e36f07410
doc_id: 770969
cord_uid: uozhkvtu

nan

Few infectious diseases have posed such tremendous challenges as the Coronavirus Disease 2019 2 (COVID-19), sweeping across 216 countries or territories by August 29. In response, an 3 unprecedented upsurge of research has been witnessed [1] . To assess the pattern and scale of 4 COVID-19 research, we searched 'nCov', 'COVID-19', or 'SARS-CoV-2' in Embase, MEDLINE for SARS ( Figure.1A-1B) , which underscored evidence-based public health policy in modern era. 4

The global spread of COVID-19 brought substantial challenges to other health metrics, especially 5 the management of other medical conditions ( Figure.1A-1B) . In the settings of severe COVID-19 6 epidemics, healthcare services of "non-urgent" ailments have been disrupted [8] . The containment 7 strategies, such as social distancing, might negatively influence metabolic health[9]. 8 9

We also identified 1085 COVID-19 papers in preprint platforms (bioRxiv, medRxiv, ChemRxiv 10 and ChinaXiv) using the same searching strategies (Supplementary Methods and Figure. The prospect of COVID-19 pandemic is still unclear, and its influence is far-reaching. Continuous 21 research achievements will help fill the knowledge gap. However, we are left behind in some 22

aspects. For example, funds to support the development of therapeutics and vaccines for 23 SARS-CoV were reduced when SARS ended [14] , leaving us underprepared to cope with 24 COVID-19. Hopefully, reasonable research efforts will persist even after the threat subsides, 25 allowing for better preparedness for the next unexpected yet historically recurring crises. 26 27 28

Contributors 29 LZ took responsibility for the integrity of the data and the accuracy of the data analysis. GL and 30

YZ designed the study. GL, YZ, JJ, and XL collected the data and independently reviewed the data.

QJ cleaned and processed the data. GL and YZ contributed to the statistical analysis. GL, YZ, and 32

JJ drafted the manuscript. All authors contributed to data interpretation, revised the manuscript and 33

approved the final version.

Declaration of interests 36 We declare no competing interests. 

The coronavirus pandemic in five 2 powerful charts

Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis 4 and Treatment

Pricing Of COVID-19 Treatments And Coronavirus Vaccines

Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan

COVID-19 Open Access Project. Living evidence on COVID-19

Living mapping and living systematic review of Covid-19 15 studies

Remdesivir for the Treatment of Covid-19 -Preliminary Report

Digitalized 23 Adaptation of Oncology Trials during and after COVID-19

Will the COVID-19 pandemic worsen the obesity 25 epidemic?

Pandemic publishing poses a new COVID-19 challenge

Waste in covid-19 research

Retraction-Hydroxychloroquine or chloroquine with or 32 without a macrolide for treatment of COVID-19: a multinational registry analysis

Development of SARS vaccines and therapeutics is still needed

We thank Dr. Xiaole Xie and Zhenghao Fan for their great supports in data processing.

Funding 42The authors received no funding for this work. 43 J o u r n a l P r e -p r o o f